Landscapes / Companies
Calico Life Sciences LLC not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials · 4 in all
Trials
3 active
7 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
AbbVie |
Phase 1/2 | Nov 2027Phase 1/2 trial completes | ||
| Next date | Nov 2027 · Phase 1/2 trial completes | ||||
| Also tested for | Vanishing White Matter Disease | ||||
| Open drug page | |||||
— |
Phase 2 | Aug 2029Phase 2 trial completes | |||
| Next date | Aug 2029 · Phase 2 trial completes | ||||
| Also tested for | Autosomal Dominant Polycystic Kidney Disease | ||||
| Open drug page | |||||
— |
Phase 1 | — | |||
| Also tested for | Advanced Solid Tumor Cancer | ||||
| Open drug page | |||||
About
- No active trial
- ABBV-CLS-7262
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 Industry-sponsored drug trials since 2021